Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 1070-1074

  Koo, Su Pin ^a   Bayer, Arnold S ^a,b   Sahl, Hans Georg ^c   Proctor, Richard A ^d   Yeaman, Michael R ^a,b  

^a St John's Cardiovascular Research Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MENADIONE; THROMBIN;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; HOST RESISTANCE; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; THROMBOCYTE;

EID: 0030044640     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.1070-1074.1996     Document Type: Article

References (32)

1. Balwit, J. M., P. van Langevelde, J. M. Vann, and R. A. Proctor. 1994. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170:1033-1037.
2. Benz, R., G. Jung, and H.-G. Sahl. 1991. Mechanism of channel formation by lantibiotics in black lipid membranes, p. 359-372. In G. Jung and H.-G. Sahl (ed.), Nisin and novel lantibiotics. Escom Science Publishers, Leiden, The Netherlands.
3. Bierbaum, G., M. Reis, C. Szekat, and H.-G. Sahl. 1994. Construction of an expression system for engineering of the lantibiotic Pep5. Appl. Environ Microbiol. 60:4332-1338.
4. Bierbaum, G., and H.-G. Sahl. 1993. Lantibiotics - unusually modified bacteriocin-like peptides from Gram-positive bacteria. Zentralbl. Bakteriol. 278:1-22.
5. Brötz, H., G. Bierbaum, A. Markus, E. Molitor, and H.-G. Sahl. 1995. Mode of action of lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob. Agents Chemother. 39:714-719.
6. Driessen, A. J. M., H. W. van den Hooven, W. Kuiper, M. van de Kamp, H.-G. Sahl, R. N. H. Konings, and W. N. Konings. 1995. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles Biochemistry 34:1606-1614.
7. Frey, A., R. Kellner, G. Jung, and H.-G. Sahl. 1991. Frequency of lantibiotic production among coagulase-negative staphylococci. re-isolation of epidermin, p. 180-188. In G. Jung and H.-G. Sahl (ed.), Nisin and novel lantibiotics. Escom Science Publishers, Leiden, The Netherlands.
8. Ganz, T., M. E. Selsted, and R. I. Lehrer. 1990. Defensins. Eur J. Haematol. 44:1-8.
9. Garcerá, M. J. G., M. G. L. Elferink, A. J. M. Driessen, and W. N. Konings. 1992. In vitro pore-forming activity of the lantibiotic nisin: role of proton motive force and lipid composition. Eur. J. Bacteriol. 1519:417-422.
10. 2 isoprenologs by Staphylococcus aureus. J. Bacteriol. 100:573-578
11. Jung, G. 1991. Lantibiotics - ribosomally synthesized biologically active polypeptides containing sulphide bridges and α,β-didehydroamino acids. Angew. Chem. Int. Ed. Engl 30:1051-1068.
12. Koo, S.-P., A. S. Bayer, and M. R. Yeaman. 1995 Bactericidal activity of platelet microbicidal protein is modified by microenvironment and target cell growth phase, abstr. A-1, p. 17. In Abstracts of the 33rd Annual Meeting of the Infectious Diseases Society of America 1995. Infectious Diseases Society of America, Washington. D.C.
13. 12a. Koo, S.-P., M. R. Yeaman, and A. S. Bayer. Unpublished data.
14. Kordel, M., R. Benz, and H.-G. Sahl. 1988. Mode of action of the staphylococcinlike peptide Pep5 voltage-dependent depolarization of bacterial and artificial membranes. J Bacteriol. 170:84-88.
15. Mates, S. M., E. S. Eisenberg, L. J. Mandel, L. Patel, H. R. Kaback, and M. H. Miller. 1982. Membrane potential and gentamicin uptake in Staphy-lococcus aureus. Proc. Natl. Acad. Sci. USA 79:6693-6697.
16. Proctor, R. A. 1994. Microbial pathogenic factors: small colony variants, p. 79-94. In A. L. Bisno and F. A Waldvogel (ed.), Infections associated with indwelling medical devices, 2nd ed. American Society for Microbiology, Washington, D C.
17. Proctor, R. A., J. M. Balwit, and O. Vesga. 1994. Variant suhpopulations of Staphylococcus aureus as a cause of persistent and recurrent infections Infect. Agents Dis. 3:302-312
18. Sahl, H.-G. 1985. Influence of the sraphylococcinlike peptide Pep5 on the membrane potential of bacterial cells and cytoplasmic membrane vesicles. J. Bacteriol 162:833-836.
19. Sahl, H.-G. 1991. Pore formation in bacterial cells by cationic lantibiotics. p. 347-358 In G. Jung and H-G. Sahl (ed.). Nisin and novel lantibiotics. Escom Science Publishers, Leiden, The Netherlands
20. Sahl, H.-G., and H. Brandis. 1981. Production, purification, and chemical properties of an antislaphylococcal agent produced by Staphylococcus epidermidis. J. Gen. Microbiol. 127:377-384.
21. Sahl, H.-G., R. W. Jack, and G. Bierbaum. 1995. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications, Eur. J. Biochem. 230:827-853.
22. Sahl, H.-G., M. Kordel, and R. Benz. 1987. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by peptide antibiotic nism Arch. Microbiol. 149:120-124.
23. Scheld, W. M., O. Zak, K. Vosbeck, and M. A. Sande. 1978. Bacterial adherence in the pathogenesis of streptococcal endocarditis - bacterial dextran, platelets and fibrin J. Clin. Invest. 61:1394-1404.
24. Schüller, F., R. Benz, and H.-G. Sahl. 1989. The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur. J Biochem. 182:181-186.
25. Selsted, M. E., D. Szklarek, and R. I. Lehrer. 1984. Purification and anti-bacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun. 45:150-154.
26. Sullam, P. M., D. G. Payan, P. F. Dazin, and F. H. Valone. 1990. Binding of viridans group streptococci to human platelets: a quantitative analysis. Infect Immun 58:3802-3806.
27. Wu, T., M. R. Yeaman, and A. S. Bayer. 1994. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among staphylococcal isolates. Antimicrob. Agents Chemother. 38:729-732.
28. Yeaman, M. R., A. S. Ibrahim, J. E. Edwards, Jr., A. S. Bayer, and M. A. Ghannoum. 1992. Thrombin-induced platelet microbicidal protein is fungicidal in vitro. Antimicrob. Agents Chemother. 37:546-553.
29. Yeaman, M. R., S.-P. Koo, A. S. Bayer, and P. M. Sullam. 1995. Platelet microbicidal protein (PMP) induces in vitro pore formation in Staphylococcus aureus, abstr. B-26, p. 170. Abstr. 95th Annu. Meet. Am. Soc. Microbiol 1995. American Society for Microbiology, Washington, D.C.
30. Yeaman, M. R., D. C. Norman, and A. S. Bayer. 1992. Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro Infect Immun. 60:2368-2374.
31. Yeaman, M. R., S. M. Puentes, D. C. Norman, and A. S. Bayer. 1992. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein Infect. Immun. 60:1202-1209
32. 30a. Yeaman, M. R., T. Wu, C. Nast, C. Itatani, and A. S. Bayer. Unpublished data